Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214331 | SCV000272757 | uncertain significance | not specified | 2015-06-11 | criteria provided, single submitter | clinical testing | The p.Val22475Phe variant in TTN has not been previously reported in individuals with cardiomyopathy, but has been identified in 0.1% (13/16460) of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs559907766). Computational prediction tools and conservation analy sis do not provide strong support for or against an impact to the protein. In su mmary, the clinical significance of the p.Val22475Phe variant is uncertain. |
Labcorp Genetics |
RCV000528371 | SCV000643663 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-08-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002327092 | SCV002634380 | uncertain significance | Cardiovascular phenotype | 2019-08-06 | criteria provided, single submitter | clinical testing | The p.V15978F variant (also known as c.47932G>T), located in coding exon 153 of the TTN gene, results from a G to T substitution at nucleotide position 47932. The valine at codon 15978 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003137815 | SCV003827898 | uncertain significance | not provided | 2023-10-27 | criteria provided, single submitter | clinical testing |